Search - tctmd.com

Displaying 1 - 20 of 71

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2025

The Future of Drug Coated Balloons: Moving on to De Novo Disease?

Presenter: Suhail Dohad

November 13, 2025

Presentation TCT India 2025

Imaging to define plaque preparatory strategy using IVUS, OCT, and other novel catheters

Presenter: Gary S. Mintz

July 26, 2025

Presentation ESC 2024

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Presenter: Ling Tao

September 02, 2024

Presentation TCT Abstracts Posters 2018

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

Presenter: Cigdem Koca Tari

September 25, 2018

Presentation TCT 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: George L Adams, Tony Das, Klaus Brechtel

September 21, 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk –a randomized controlled single-blind multicenter trial (DEBUT)

Presentation EuroPCR 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

Presentation EuroPCR 2018

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

Presentation JIM 2018

The Elixir DynamX Program: A "Novel" Metallic DES with Adaptive Remodeling

Presenter: Martin B. Leon

February 23, 2018

Presentation JIM 2017

FORTITUDE, APTITUDE and MAGNITUDE: Other Thin-Strut Novel PLLA-Based Scaffolds

Presenter: Azeem Latib

February 08, 2017

Presentation JIM 2017

DESolve: A Family of Novel PLLA-Based Scaffolds

Presenter: Martin B. Leon

February 08, 2017

Presentation TCT 2016

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso

November 02, 2016

Presentation TCT 2016

TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Giulio Guagliumi

November 02, 2016

Presentation TCT 2016

TOSCA-5: A Prospective, Randomized Trial Evaluating Collagenase Infusion in Patients With Coronary Artery Chronic Total Occlusions

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Christopher E. Buller

November 02, 2016

Presentation TCT 2016

PRISON IV: A Prospective, Randomized Trial of a Bioresorbable Polymer-Based Sirolimus-Eluting Stent and a Durable Polymer-Based Everolimus-Eluting Stent in Patients With Coronary Artery Chronic Total Occlusions

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Koen Teeuwen

November 02, 2016

Presentation TCT 2016

PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities

Presenter: Howard C. Herrmann, Robert J. de Winter, Wayne B. Batchelor

November 01, 2016

Presentation JIM 2016

Novel Imaging and Physiologic Lesion Assessment Devices to Guide BRS procedures

Presenter: Azeem Latib

February 10, 2016

Presentation JIM 2016

DESolve Update:From NX to novel platforms

Presenter: Alexandre Abizaid

February 10, 2016

Presentation ESC 2015

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Presenter: Takeshi Kimura

September 01, 2015

Presentation BRS 2015

Novel Vascular Responses of BRS (Absorb and Beyond): Insights From Serial Imaging and Vasomotion Studies

Presenter: Patrick W. Serruys, Y. Onuma

February 10, 2015

Presentation AHA 2014

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Presenter: Dean J. Kereiakes

November 16, 2014

Advertisement

The Future of Drug Coated Balloons: Moving on to De Novo Disease?

Imaging to define plaque preparatory strategy using IVUS, OCT, and other novel catheters

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Clinical Outcomes of Patients Undergoing Novolimus-eluting Bioresorbable Scaffolds

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

The Elixir DynamX Program: A "Novel" Metallic DES with Adaptive Remodeling

FORTITUDE, APTITUDE and MAGNITUDE: Other Thin-Strut Novel PLLA-Based Scaffolds

DESolve: A Family of Novel PLLA-Based Scaffolds

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

TOSCA-5: A Prospective, Randomized Trial Evaluating Collagenase Infusion in Patients With Coronary Artery Chronic Total Occlusions

PRISON IV: A Prospective, Randomized Trial of a Bioresorbable Polymer-Based Sirolimus-Eluting Stent and a Durable Polymer-Based Everolimus-Eluting Stent in Patients With Coronary Artery Chronic Total Occlusions

PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities

Novel Imaging and Physiologic Lesion Assessment Devices to Guide BRS procedures

DESolve Update:From NX to novel platforms

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Novel Vascular Responses of BRS (Absorb and Beyond): Insights From Serial Imaging and Vasomotion Studies

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content